↓ Skip to main content

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer

Overview of attention for article published in BMC Cancer, February 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer
Published in
BMC Cancer, February 2012
DOI 10.1186/1471-2407-12-58
Pubmed ID
Authors

Atil Bisgin, Aysegul Kargi, Arzu D Yalcin, Cigdem Aydin, Deniz Ekinci, Burhan Savas, Salih Sanlioglu

Abstract

Colorectal cancer is the third most common cancer and the third leading cause of cancer-related death. Bevacizumab is a humanized monoclonal antibody developed against vascular endothelial growth factor (VEGF) for the treatment of metastatic cancer. The parameters of RECIST (Response Evaluation Criteria for Solid Tumors) are not adequate to detect important treatment effects and response. Our goal was to evaluate the possibility of using sTRAIL (serum-soluble TNF-related apoptosis-inducing ligand) and VEGF as markers of treatment efficacy and prognosis in patients with metastatic colon cancer.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 8%
Unknown 12 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 23%
Student > Bachelor 2 15%
Student > Ph. D. Student 2 15%
Student > Master 1 8%
Other 1 8%
Other 2 15%
Unknown 2 15%
Readers by discipline Count As %
Medicine and Dentistry 5 38%
Immunology and Microbiology 1 8%
Nursing and Health Professions 1 8%
Biochemistry, Genetics and Molecular Biology 1 8%
Engineering 1 8%
Other 0 0%
Unknown 4 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2012.
All research outputs
#4,207,094
of 5,038,248 outputs
Outputs from BMC Cancer
#2,251
of 2,818 outputs
Outputs of similar age
#194,124
of 236,973 outputs
Outputs of similar age from BMC Cancer
#62
of 73 outputs
Altmetric has tracked 5,038,248 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,818 research outputs from this source. They receive a mean Attention Score of 2.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,973 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.